HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lizzia Raffaghello Selected Research

Neuroectodermal Tumors (Neuroectodermal Tumor)

4/2022Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors.
4/2006Immunotherapy of neuroblastoma: present, past and future.
10/2005Mechanisms of immune evasion of human neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lizzia Raffaghello Research Topics

Disease

34Neoplasms (Cancer)
01/2018 - 02/2004
26Neuroblastoma
04/2022 - 05/2003
8Starvation
06/2018 - 06/2008
5Inflammation (Inflammations)
01/2022 - 02/2015
4Melanoma (Melanoma, Malignant)
04/2022 - 05/2003
4Muscular Dystrophies (Muscular Dystrophy)
01/2022 - 01/2019
4Neoplasm Metastasis (Metastasis)
01/2018 - 04/2009
3Neuroectodermal Tumors (Neuroectodermal Tumor)
04/2022 - 10/2005
3Fibrosis (Cirrhosis)
01/2022 - 01/2012
3Breast Neoplasms (Breast Cancer)
01/2016 - 02/2010
3Carcinoma (Carcinomatosis)
01/2016 - 05/2015
2Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2022 - 01/2021
2Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 08/2020
2Autoimmune Diseases (Autoimmune Disease)
02/2017 - 03/2010
2Glioma (Gliomas)
02/2010 - 06/2008
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2021
1Sarcoglycanopathies
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2018
1Body Weight (Weight, Body)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2017
1Colonic Neoplasms (Colon Cancer)
05/2015
1Colorectal Neoplasms (Colorectal Cancer)
05/2015
1Hypoxia (Hypoxemia)
11/2014
1Atherosclerosis
01/2012
1Myocardial Infarction
01/2012
1Stroke (Strokes)
01/2012

Drug/Important Bio-Agent (IBA)

9Adenosine Triphosphate (ATP)IBA
04/2022 - 07/2008
7Glucose (Dextrose)FDA LinkGeneric
06/2018 - 06/2008
5CytokinesIBA
01/2017 - 01/2004
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 07/2003
5Proteins (Proteins, Gene)FDA Link
01/2013 - 09/2004
5AntigensIBA
01/2012 - 09/2004
4Purinergic P2X7 ReceptorsIBA
01/2022 - 01/2006
4Messenger RNA (mRNA)IBA
01/2017 - 01/2004
4ChemokinesIBA
01/2011 - 02/2004
3Pharmaceutical PreparationsIBA
04/2022 - 05/2003
3Biological ProductsIBA
01/2017 - 06/2003
3micaIBA
01/2013 - 09/2004
3HLA-G Antigens (HLA G)IBA
01/2013 - 07/2007
3Insulin-Like Growth Factor I (IGF-1)IBA
02/2012 - 02/2010
3HLA Antigens (Human Leukocyte Antigens)IBA
06/2007 - 09/2004
3LigandsIBA
07/2005 - 02/2004
3FenretinideIBA
07/2003 - 05/2003
2Therapeutic UsesIBA
04/2022 - 01/2017
2Sarcoglycans (beta Sarcoglycan)IBA
01/2022 - 01/2019
2AlarminsIBA
01/2021 - 01/2019
2Protein Isoforms (Isoforms)IBA
01/2021 - 07/2007
2EnzymesIBA
01/2018 - 12/2015
2InterferonsIBA
01/2017 - 05/2013
2Bevacizumab (Avastin)FDA Link
01/2017 - 06/2012
2Metformin (Glucophage)FDA LinkGeneric
01/2016 - 01/2016
2LuciferasesIBA
02/2015 - 07/2008
2TenascinIBA
11/2014 - 10/2011
2Histocompatibility Antigens Class IIBA
05/2013 - 06/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2012 - 07/2011
2Caspase 3 (Caspase-3)IBA
03/2012 - 01/2006
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2011 - 01/2011
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2010 - 06/2008
2buthionineIBA
02/2008 - 10/2005
2Monoclonal AntibodiesIBA
07/2005 - 12/2004
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2022
1UbiquitinIBA
04/2022
1Glutamine (L-Glutamine)FDA Link
04/2022
1Purinergic Receptors (Receptors, Purine)IBA
01/2022
1HMGB1 Protein (HMG1)IBA
01/2021
1InflammasomesIBA
08/2020
1ectoATPaseIBA
01/2019
1PolyphenolsIBA
01/2018
1NF-kappa B (NF-kB)IBA
01/2018
1CurcuminIBA
01/2018
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2017
1Chimeric Antigen ReceptorsIBA
01/2017
1Chloroquine (Aralen)FDA LinkGeneric
01/2017
1HexokinaseIBA
01/2016
1Adenosine (Adenocard)FDA LinkGeneric
01/2016
1Diphosphates (Pyrophosphates)IBA
01/2016
1adenylyl(3'-5')cytidine-3'-phosphateIBA
01/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2015
1Purinergic P2 Receptors (ADP Receptor)IBA
02/2015
1HMGB ProteinsIBA
11/2014
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
07/2013
1Zoledronic Acid (Zometa)FDA Link
05/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2013
1ProteomeIBA
01/2013
12',3'-dialdehyde ATPIBA
06/2012
1NFATC Transcription FactorsIBA
06/2012
1Phosphotransferases (Kinase)IBA
03/2012
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
02/2012
1Insulin-Like Growth Factor Binding Protein 1IBA
02/2012
1Peptides (Polypeptides)IBA
01/2012
1Oncogene Proteins (Oncogene Protein)IBA
01/2012
1LipidsIBA
01/2012
1Tacrolimus (Prograf)FDA LinkGeneric
01/2012
1HMW-MAAIBA
10/2011
1Interleukin-6 (Interleukin 6)IBA
07/2011

Therapy/Procedure

10Therapeutics
02/2017 - 05/2003
6Drug Therapy (Chemotherapy)
05/2015 - 06/2008
4Immunotherapy
01/2017 - 04/2006
1Intravenous Administration
01/2017
1Stem Cell Transplantation
01/2012